Stay updated with breaking news from Thierry Andre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Thierry Andre, MD, discusses the efficacy of trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer and the safety profiles of the 2 arms of the phase 3 SOLSTICE trial.
Calls to Mr. Roger often traced back to a simple cocktail party question: Where’d you get that dress?
Thierry Andre, MD, discusses negative overall survival results and updated safety data from the phase 3 SOLSTICE trial in metastatic colorectal cancer.
In a small study, just over half (59%) of patients who had combination immunotherapy showed no sign of tumor on preoperative endoscopy.
Neoadjuvant treatment with checkpoint inhibitors, followed by surgery and adjuvant immunotherapy, appears effective in MSI/dMMR gastric/GEJ cancer.